Corindus Vascular Robotics Aktie [WKN DE: A14V14 / ISIN: US2187301096]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Corindus Vascular Robotics

25.10.19		Corindus Vascular Robotics, Inc. Stockholders Approve Acquisition by Siemens Healthineers (Businesswire)
18.09.19		Corindus to Showcase CorPath® GRX System at Transcatheter Cardiovascular Therapeutics 2019 Conference (Businesswire)
03.09.19		First-in-Human Telerobotic Coronary Intervention Procedures Published in The Lancet Journal, EClinicalMedicine (Businesswire)
08.08.19		Corindus Reports Second Quarter 2019 Results (Businesswire)
08.08.19		DERM On Watchlist, FDA Panel Nod For GILD, So Long, CVRS And AVDR (RTTNews)
08.08.19		Siemens Healthineers To Buy Corindus Vascular Robotics For About $1.1 Bln (RTTNews)
08.08.19		Corindus Vascular Robotics Announces Definitive Agreement to Be Acquired by Siemens Healthineers (Businesswire)
05.08.19		Corindus to Present at Canaccord Genuity 39th Annual Growth Conference on August 8, 2019 (Businesswire)
25.07.19		Corindus to Report Second Quarter 2019 Financial Results on August 8, 2019 (Businesswire)
18.07.19		Corindus Adds Two New CorPath GRX Installations to HCA Healthcare Facilities (Businesswire)
17.07.19		Corindus Announces Regulatory Approval of CorPath GRX for Neurovascular Intervention in Australia and New Zealand (Businesswire)
09.07.19		Corindus Announces First Commercial Installation of CorPath® GRX System in South America (Businesswire)
01.07.19		Corindus Joins Russell 3000® Index (Businesswire)
23.05.19		Corindus CorPath GRX System Successfully Used in Live Complex Robotic-Assisted Coronary Intervention at EuroPCR 2019 (Businesswire)
20.05.19		Corindus to Showcase CorPath® GRX Robotic System at EuroPCR 2019 (Businesswire)
17.05.19		Corindus to Present "Evolution of Robotics: Automation, Remote Applications, and Beyond” at SCAI 2019 Breakfast Symposium on May 21, 2019 (Businesswire)
07.05.19		Corindus Reports First Quarter 2019 Results (Businesswire)
07.05.19		Corindus Equips the World’s First Fully Robotic Catheterization Laboratory (Businesswire)
29.04.19		Corindus to Report First Quarter 2019 Financial Results on May 7, 2019 (Businesswire)
15.04.19		Corindus Announces First Robotic-Assisted Interventions in Japan for CorPath GRX Post-Market Study (Businesswire)
29.03.19		Corindus Vascular Robotics Files Required Registration Statement for Holders of Recently Completed $19.8 Million Private Placement (Businesswire)
12.03.19		Corindus Reports Fourth Quarter and Full Year 2018 Results (Businesswire)
12.03.19		Corindus Vascular Robotics Announces Additional Closing of Private Placement (Businesswire)
05.03.19		Corindus to Report Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019 (Businesswire)
05.03.19		Corindus to Present at 39th Annual Cowen Health Care Conference on March 13, 2019 (Businesswire)
26.02.19		Corindus Vascular Robotics Announces Closing of Private Placement for $15 Million (Businesswire)
14.02.19		Corindus Announces FDA Submission for Neurovascular Intervention Indication for CorPath® GRX Vascular Robotic System (Businesswire)
06.12.18		Corindus’ Technology Successfully Used in World’s First-in-Human Telerobotic Coronary Intervention (Businesswire)
07.11.18		Corindus to Present at Upcoming 2018 Healthcare Conferences (Businesswire)
06.11.18		Corindus Reports Third Quarter 2018 Results (Businesswire)
30.10.18		Corindus to Report Third Quarter Financial Results on November 6, 2018 (Businesswire)
01.10.18		Corindus Technology Successfully used in Multiple Live Complex Robotic-Assisted Coronary Interventions at Transcatheter Cardiovascular Therapeutics 2018 (Businesswire)
24.09.18		Corindus Announces First Live Transmission of Remote Robotic Demonstration Performed at Transcatheter Cardiovascular Therapeutics 2018 Conference (Businesswire)
17.09.18		Corindus to Present at Ladenburg Thalmann 2018 Healthcare Conference (Businesswire)
23.08.18		Corindus to Present at 13th Annual Wells Fargo Securities Healthcare Conference (Businesswire)
07.08.18		Corindus Reports Second Quarter 2018 Results (Businesswire)
06.08.18		Corindus to Showcase CorPath GRX® System for Peripheral Vascular Interventions at the 2018 Amputation Prevention Symposium (Businesswire)
03.08.18		Corindus to Report Second Quarter Financial Results on August 7, 2018 (Businesswire)
03.08.18		Corindus to Present at Canaccord Genuity 38th Annual Growth Conference (Businesswire)
19.07.18		Corindus Announces Significant Progress in the Development of Remote Vascular Robotic Technology with the CorPath GRX® System (Businesswire)
11.07.18		Corindus Names Aquilla S. Turk, D.O. as Chief Medical Officer, Neuroendovascular (Businesswire)
19.06.18		Corindus Promotes Doug Teany to Chief Operating Officer (Businesswire)
08.06.18		Corindus Announces Pharmaceutical and Medical Device Agency (PMDA) Approval of CorPath GRX System in Japan (Businesswire)
08.05.18		Corindus Reports First Quarter 2018 Results (Businesswire)
27.04.18		Corindus to Report First Quarter Financial Results on May 8, 2018 (Businesswire)
23.04.18		Corindus Presents "Optimizing Care with CorPath GRX: Hot Topics in Robotic Interventions" at SCAI 2018 Dinner Symposium on April 26 (Businesswire)
16.03.18		Corindus Announces $25 Million Private Placement of Series A Convertible Preferred Shares and Warrants (Businesswire)
14.03.18		Corindus Reports Fourth Quarter and Full Year 2017 Results (Businesswire)
13.03.18		Corindus to Report Fourth Quarter and Full Year 2017 Financial Results on March 14, 2018 (Businesswire)
13.03.18		James R. Tobin Joins Corindus Board of Directors (Businesswire)

1 | Weiter

Newssuche

Meistgelesene Nachrichten

Elon Musk prognostiziert Kursrückgang bei Bitcoin

Solana Kurs Prognose: 1.000 US-Dollar in 2025?

Palantir-Aktie nach Gewinn- und Umsatzplus deutlich höher

100.000-Dollar-Schwelle unterschritten: Bitcoin gibt nach

DeepSeek sorgt für Turbulenzen an den Krypto-Märkten - Crash oder Kaufgelegenheit?

Bitcoin, Ether und Co. im Check - ChatGPTs Top-Kryptowährung für 2025

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	04.02.2025 21:49
Kaufwert:	EUR
	Hinzufügen Speichern